Stryker Launches Mako 4 SmartRobotics in India for Advanced Joint Replacement

In October 2026, Stryker launched Mako 4 SmartRobotics in India, introducing its fourth-generation robotic-arm assisted technology to the country's orthopedic healthcare sector. The platform is designed to support surgeons during total knee, partial knee, and total hip replacement procedures by combining patient-specific planning, robotic assistance, 3D CT-based technology, and haptic guidance. The launch reflects the growing adoption of advanced surgical technologies designed to support precision and personalized treatment in orthopedic procedures.

Mako 4 combines 3D CT-based planning with AccuStop haptic technology to help surgeons develop and execute procedures according to each patient's individual anatomy. The technology enables patient-specific planning before surgery and provides real-time intraoperative guidance during the procedure. By bringing planning and robotic assistance together within one platform, Mako 4 is designed to provide a more integrated clinical and operational experience for healthcare providers.

The platform supports three orthopedic applications, including Mako Total Knee, Mako Partial Knee, and Mako Total Hip with advanced primary and revision capabilities. This enables the technology to address multiple joint replacement procedures through a single robotic platform. The system's combination of imaging, surgical planning, robotic assistance, and haptic guidance highlights the increasing integration of digital technologies into orthopedic surgery.

The introduction of Mako 4 also builds on the established Mako platform, which has been used for more than 2.5 million procedures across 47 countries, according to Stryker. The launch in India expands access to the company's latest generation of robotic-assisted orthopedic technology and demonstrates the increasing role of advanced medical technology in the country's healthcare sector.

Impact on the Orthopedic Robotics Market

The global orthopedic devices market size is calculated at USD 65.79 billion in 2025 and is predicted to increase from USD 68.64 billion in 2026 to approximately USD 100.33 billion by 2035, expanding at a CAGR of 4.31% from 2026 to 2035. Mako 4 is specifically designed for total knee, partial knee, and total hip procedures, making its launch directly relevant to the development of orthopedic robotics. The technology can support surgeons by connecting preoperative planning with intraoperative execution. This approach is particularly valuable for procedures where accurate planning and controlled execution are important components of the surgical process.

The growing focus on patient-specific treatment is another factor supporting orthopedic robotic technologies. Instead of relying only on standardized approaches, platforms such as Mako 4 use information from individual patient anatomy to support surgical planning. This reflects the broader movement toward personalized and precision-driven healthcare.

Impact on the Robotic Surgery Market in India

The global robotic surgery market size was estimated at USD 11.83 billion in 2024 and is anticipated to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% from 2025 to 2034.

The launch of Mako 4 in India highlights the increasing availability of advanced robotic-assisted surgical technologies in the country. Healthcare providers are increasingly investing in modern medical technologies to expand their capabilities and support complex surgical procedures.

India's growing healthcare infrastructure and increasing demand for advanced orthopedic treatment are creating opportunities for robotic-assisted surgery. The availability of technologies designed specifically for knee and hip replacement can support hospitals seeking to strengthen their orthopedic services.

However, the adoption of robotic surgical platforms also depends on factors such as hospital infrastructure, technology investment, and availability of trained healthcare professionals. Continued development of surgical training and expansion of advanced healthcare facilities can support wider adoption of robotic-assisted technologies.

Future Opportunities

The development of Mako 4 demonstrates the continued integration of robotics, 3D imaging, patient-specific planning, and haptic guidance in orthopedic surgery. These technologies are creating opportunities for medical technology companies to develop increasingly integrated surgical platforms.

Future advancements in robotic-assisted surgery are expected to focus on improving the connection between preoperative imaging and intraoperative guidance. Greater integration of digital planning and robotic assistance could further support personalized surgical workflows.
The launch of Mako 4 SmartRobotics in India therefore represents an important development in robotic-assisted orthopedic surgery. By combining 3D CT-based planning, robotic assistance, and haptic guidance, the platform supports the industry's movement toward more precise and technology-enabled joint replacement procedures. As healthcare providers continue to adopt advanced surgical technologies, robotic-assisted platforms are expected to remain an important area of innovation within orthopedic healthcare.